China Genome-Based Drug Industry Forecasts 2022: Demand to Grow by 9% Through 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Genome-Based Drug Industry Forecasts – China Focus” report has been added to ResearchAndMarkets.com’s offering.

This study focuses on China’s Genome-Based Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumption in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products.

Far outpacing other economies in the world, China is the world’s fastest growing market for the consumption of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study focuses on industry trends and forecasts with historical data (2011, 2016 and 2021) and long-term forecasts through 2026 and 2031 are presented.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases.

The author is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. They have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. The report provides hard-to-find market data and analyses. The publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.

Key Topics Covered:

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population and Labor
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

• Overview
• Genome-Based Drug Sales Volumes and Forecasts (Yuan)
• Cytokines Drug
• Peptide Hormones Drug
• Thrombolytic Agents
• Enzyme Drug
• Soluble Recepter
• Adhesion Molecule
• Nucleic Acid Drug
• Other Genome-Based Drug
• Genome-Based Drug Imports and Exports
• Pricing Trends

For more information about this report visit https://www.researchandmarkets.com/r/yhkpns

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900